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Eating disorders have a profound and highly speciﬁc impact on psychosocial functioning. The aim of this
research was to develop a measure of such secondary impairment. A 16-item, self-report instrument was
developed, the Clinical Impairment Assessment (CIA), which was designed to measure such impairment
overall and in three speciﬁc domains (personal, cognitive, social). The psychometric properties of the
instrument were evaluated using data collected in the context of a transdiagnostic treatment trial. The
ﬁndings consistently supported the utility of the instrument with the CIA being shown to have high
levels of internal consistency, construct and discriminant validity, test–retest reliability, and sensitivity to
change. The CIA should be of value to clinicians when assessing patients with eating disorders and their
response to treatment. It should also help inform epidemiological research.
 2008 Elsevier Ltd.Open access under CC BY license.Introduction
The assessment of psychopathology requires not only an eval-
uation of the nature and severity of particular features, but also an
assessment of the impact of these features on the person’s psy-
chosocial and physical functioning. This is important for at least
two reasons: ﬁrst, it is often impairment that leads people to seek
help and a goal of treatment should therefore be to reduce it; and
second, the presence of clinically signiﬁcant impairment is required
to make a diagnosis of a mental disorder (American Psychiatric
Association, 1994). Despite this, measures of psychopathology have
tended to focus on the psychopathology itself and not the impair-
ment that it causes. Recently this tendency has been countered to
an extent with the increasing use of measures of ‘‘health-related
quality of life’’ to supplement the assessment of symptoms.
Although valuable, these generic measures, developed originally to
assess the impact of physical illnesses on everyday functioning
(Ware, Kosinski, & Keller, 1996; Ware, Snow, Kosinski, & Reese,
1993; WHOQOL Group, 1998), may miss important sources of
impairment that are peculiar to psychopathology and to the char-
acteristics of particular psychiatric disorders.
Eating disorders are a case in point for they have profound and
speciﬁc effects on psychosocial functioning. For example, these
patients’ over-evaluation of shape and weight and its expressions,: þ44 1865 226244.
Y license.the so-called ‘‘core psychopathology’’ (Fairburn, 2008), has
a marked effect on their ability to be with others and to form in-
timate personal relationships. Similarly, their concerns about eat-
ing, and its expressions, prevent them from eating healthily,
affecting their mood, cognitive function and family relationships.
Secondary effects of this type can be extremely disabling yet are
likely to be missed by generic measures of health-related quality of
life (Doll, Petersen, & Stewart-Brown, 2005). For this reason disor-
der-speciﬁc measures are required.
Four eating disorder-speciﬁc measures of health-related quality
of life have recently been developed (Abraham, Brown, Boyd, Lus-
combe, & Russell, 2006; Adair et al., 2007; Engel et al., 2006; Las
Hayas et al., 2006). However, none of the four measures is entirely
satisfactory as a measure of impairment secondary to the whole
range of eating disorder psychopathology. Themainproblems are as
follows. First, three of the instruments confound the measurement
of eating disorder psychopathology with the assessment of im-
pairment and fail to ensure that the impairment assessed is sec-
ondary to eating disorder psychopathology (Abraham et al., 2006;
Adair et al., 2007; Las Hayas et al., 2006). Second, three instruments
omit to assess the impact of the patients’ extreme concerns about
their shape (Abraham et al., 2006; Engel et al., 2006; Las Hayas et al.,
2006) and as a result are likely to underestimate the extent of the
secondary impairment. Third, sensitivity to change was only
examined in one of the four studies (Abraham et al., 2006). Fourth,
none of the instruments have been validated against independent
assessments of the extent of secondary impairment and none has
been evaluated in terms of its ability to predict case status.
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measure of the psychosocial impairment that results from eating
disorder features and to test its reliability, validity, sensitivity to
change and ability to predict case status.
Methods
Development of the CIA
It was decided a priori that the instrument should have certain
properties to ensure it would function as an easy-to-usemeasure of
psychosocial impairment secondary to eating disorder features.
First, it needed to be a self-report questionnaire. Second, it needed to
be compatible with a current-state measure of eating disorder fea-
tures so that together the two instruments would provide an as-
sessment of psychopathology and its resulting impairment. The
Eating Disorder Examination Questionnaire (EDE-Q) (Fairburn &
Beglin, 1994) was chosen as the measure of eating disorder psy-
chopathologyas it iswidely used and has been extensively validated
(Peterson & Mitchell, 2005). Thus the new measure of impairment,
named the Clinical Impairment Assessment (CIA), was designed to
have the same Likert-style response format as the EDE-Q and the
same time frame (covering the previous 28 days) so that re-
spondents could easilymove fromcompletingone instrument to the
completion of the other. Third, it was decided that the CIA should be
relatively brief so that the two instruments could be completed to-
gether in a short period of time (approximately 10 min). Fourth, to
maximise clinical utility, it was decided that the instrument should
generate a single, readily-calculated, overall score indicative of the
severity of secondary impairment, although the possibility of gen-
erating domain-speciﬁc scores was to be explored. Lastly, it was
decided to focus exclusively on secondary psychosocial impairment
rather than the physical effects of eating disorder psychopathology
as the subjective physical consequences of an eating disorder (e.g.,
weakness, feeling faint or cold, palpitations, muscle twitches and
spasms) are mostly non-speciﬁc in character and difﬁcult for the
individual to ascribe to their way of eating.
Two main considerations governed decision-making regarding
the content of the CIA. First, it needed to assess the inﬂuence of all
the main elements of eating disorder psychopathology on a per-
son’s functioning. Hence it was decided that the CIA should open
with the following stem question: ‘‘Over the past month, to what
extent have your eating habits, exercising or feelings about your
eating, shape or weight affected.’’. We decided not to include
purging in the stem question as ‘‘eating habits’’ includes vomiting
and laxative misuse in most patients’ minds and, having just
completed the EDE-Q, participants will have these forms of be-
haviour in their mind. Second, it was decided that the CIA should
ask about the main aspects of life that are affected by eating dis-
order psychopathology. These were identiﬁed by KB, ZC, CGF and
RLP on the basis of their clinical experience, the content of generic
measures of health-related quality of life, and the responses of
eating disorder patients to exploratory interviews focused on the
presence and nature of any secondary psychosocial impairment
that they were experiencing (Bohn, 2006). Examples of impairment
within the identiﬁed domains of life were speciﬁed resulting in the
eventual development of a 22-item instrument with 7 items di-
rected at effects on mood and self-perception, 4 at effects on cog-
nitive functioning, 7 at impairment of interpersonal functioning,
and 4 at effects on work performance. Each item was rated on a 4-
point Likert scale, where 0 (‘‘Not at all’’) was equivalent to no
impairment and 3 (‘‘A lot’’) to severe impairment. The total score
(‘global CIA score’) was designed to provide an overall index of
severity of current secondary psychosocial impairment. This
preliminary version of the CIAwas evaluated using data collected in
the context of a treatment trial.Assessment of the psychometric properties of the CIA
Participants
CIA data were collected from 123 of 170 patients who were
participating in a transdiagnostic cognitive behaviour therapy trial
based in two eating disorder clinics in the UK (Oxford and Leicester)
(Fairburn et al., in press). Both clinics provide the only secondary
adult eating disorder service for the locality. Patients were included
if they met the following criteria: aged 18–65 years, judged to have
an eating disorder of clinical severity by one of three senior spe-
cialists in the ﬁeld (ZC, CGF or RLP), and had a body mass index
between 16.0 and 39.9. The CIA data of patients who were di-
agnosed as suffering from a severe co-existing clinical depression
were excluded as some of their impairment might have been sec-
ondary to the clinical depression rather than their eating disorder
features. Details of how this judgement was made are provided
elsewhere (Fairburn, Cooper, & Waller, 2008).
The CIAwas introduced after 120 of the 170 patients had started
treatment with the consequence that pre-treatment CIA data were
collected on only 50 of the patients. A further 73 patients con-
tributed data between the end of treatment and end of their post-
treatment follow-up. Of these 123 patients, 27 (22.0%) completed
the CIA once, 44 (34.9%) twice, 30 (24.4%) three times, 17 (13.8%)
four times, and 5 (4.1%) ﬁve times, with there being 298 CIA ratings
in total over all patients and assessment points. The baseline DSM-
IV diagnoses of the 123 patients were as follows: anorexia nervosa
– 8 (6.5%); bulimia nervosa – 48 (39.0%); eating disorder NOS – 67
(54.5%). Full details of the complete sample and its response to
treatment are provided elsewhere (Fairburn et al., in press).
Assessments
Each patient underwent a research assessment at the beginning
and end of their treatment, and at 20, 40, 60, 104 and 208 weeks
post-treatment. At each point they completed the EDE-Q and, im-
mediately afterwards (from the time of its introduction), the CIA. In
addition, a trained research assistant administered the Eating Dis-
order Examination (EDE) interview (Fairburn & Cooper, 1993) to-
gether with an investigator-based interview designed to identify
secondary functional impairment (Bohn, 2006). In Oxford, ZC and
CGF also independently assessed (using an unstructured clinical
interview) the extent to which the patient’s eating disorder fea-
tures had been interfering with their psychosocial functioning over
the previous 28 days and rated this on a seven-point severity scale
(0–6, with 0 being equal to no secondary impairment and 6 being
equal to severe impairment). Finally CGF determined whether the
patient should be viewed as suffering from an eating disorder of
clinical severity. This decision was based upon ratings on the EDE
and the investigator-based impairment interviews, and was made
blind to the patient’s identity, point of follow-up and responses to
the EDE-Q and CIA. A second CIAwas administered to a subset of 43
participants three days after they had completed an initial one. This
addressed the same 28-day period.
Statistical methods
Unless otherwise stated, the analyses used the data from the
ﬁrst CIA completed by each participant so as not to violate the
assumption of statistical independence. When data collected across
multiple assessments were used to increase statistical power,
a variety of multilevel models, with a random effect for subject,
were ﬁtted to allow for correlation between repeated assessments
and to assess the impact of statistical non-independence (Singer &
Willett, 2003). Statistical signiﬁcance was taken throughout at
two-tailed p< 0.05.
Internal consistency and dimensionality. Cronbach’s alpha and
item-total correlations were used to assess internal consistency.
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the factors to be independent) and oblimin (allowing the factors to
be associated) rotations was used to assess dimensionality. In ad-
dition, Item Response Theory (IRT) with the ﬁtting of a one-
parameter Rasch model was used to explore the unidimensionality
of the questionnaire and any identiﬁed domains, and to assess the
performance of each item (Andrich, 1988; Avlund, Kreiner, &
Schultz-Larsen, 1993; Hambleton & Jones, 1993). A Rasch model is
equivalent to a test of the theoretical construct validity and ade-
quacy of a scale. It assumes that as a person’s disability or symp-
toms increase, the probability of a maximum score on each item
increases.
Test–retest reliability. An intra-class correlation coefﬁcient (ICC)
was calculated between the global CIA scores at the two time
points. In addition, a paired samples t-test was used to examine any
difference between the pairs of scores.
Construct validity. Two tests of construct validity were performed.
First, on the assumption that there would be a positive association
between the severity of eating disorder features and the extent of
psychosocial impairment secondary to them, mean global CIA
scores were compared with the global EDE-Q score using Spear-
man’s correlation coefﬁcient. The second and stronger test of
construct validity involved comparing mean global CIA scores with
the corresponding clinicians’ impairment ratings. This comparison
was performed at the ﬁrst assessment conducted on each patient,
over all time points and at each individual time point to assess
whether the agreement was independent of point of assessment. In
addition, over all assessments, a one-way ANOVAwas performed to
examine the relationship between the global CIA score and the
clinicians’ impairment ratings (with clinicians’ ratings of 5 and 6
being combined since a rating of 6 was made only once out of the
142 ratings). Post-hoc tests were performed using Tukey’s B pro-
cedure. Finally, a test of linearity was conducted. Multilevel models
were ﬁtted to allow for correlation between repeated measures.
Discriminant validity. The discriminant validity of the CIA was ﬁrst
assessed using an independent samples t-test comparing the global
CIA scores of participants who were, and were not, classed as
having an eating disorder of clinical severity. The analysis was re-
peated at each assessment and over all assessments, with multi-
level models being ﬁtted to allow for correlation between repeated
measures. Second, the performance of the CIA at predicting pa-
tients’ case status was tested using a Receiver Operating Curve
(ROC) signal detection analysis. This involved plotting sensitivity
against 1 minus speciﬁcity for each possible cut-off point on the
global CIA score, and on each domain score, thereby obtaining a full
proﬁle of the instrument’s performance (Charman et al., 2007;
Hanley & McNeil, 1982).
Sensitivity to change. Sensitivity to change was tested in two ways:
ﬁrst, pre- and post-treatment CIA data were compared using
a paired samples t-test; and second, changes in global CIA scores
from pre- to post-treatment were compared with change in psy-
chosocial impairment as rated by the clinicians using Spearman’s
correlation coefﬁcient.
Results
Internal consistency and dimensionality
The 22-item preliminary version of the CIA
The internal consistency of the 22-item CIA at ﬁrst completion
was high (Cronbach’s alpha¼ 0.97). All items correlated positively
with the global CIA score, with the item-total correlations rangingfrom 0.59 to 0.85. On IRT analysis, the 22-item questionnaire was
signiﬁcantly non-unidimensional (X2¼ 61.7, df¼ 44, p¼ 0.04).
The 16-item CIA
Since the 22-item CIA was not unidimensional and contained
ﬁve items that either had a notable ﬂoor effect, signiﬁcantly misﬁt,
or whose responses were inconsistent with the underlying con-
struct (full details available from the authors), these items were
excluded leaving a 17-item instrument. On principal components
factor analysis 2 of the 17 items did not load clearly on any one
domain. Since one of these items was judged to be of particular
clinical relevance and had the highest initial item-total correlation
(0.85), it was retained.
On principal components factor analysis, the resulting 16-item
instrument (the CIA) fell into two components explaining 71% of
the variance. The larger component consisted of one set of items
with high loadings (>0.86) and one set with low loadings (between
0.41 and 0.59). Forcing a three component solution generated three
factors (see Table 1) which explained 77% of the variance. The three
factors might best be described as personal, social and cognitive
impairment, respectively. The varimax and oblimin solutions gen-
erated similar factors. On IRT analysis, the instrument was unidi-
mensional (X2¼ 32.6, df¼ 32, p¼ 0.44), as was each of the three
individual domains, making it appropriate to create both global and
domain-speciﬁc scores. The Cronbach’s alpha for the 16-item
instrument was 0.97. The overall mean (SD) score was 20.1 (13.4),
with a range of 0–47 (possible maximum score 48).
Test–retest reliability
The mean (SD) scores of the 16-item CIA at times 1 and 2 were
10.56 (7.58) and 9.02 (8.18), respectively. While the small reduction
in score (0.20 of a standard deviation) was statistically signiﬁcant
(p¼ 0.022), the intra-class correlation coefﬁcient was high at 0.86
(95% CI 0.75–0.92; p< 0.001) indicating acceptable overall test–
retest reliability.
Construct validity
Signiﬁcant positive correlations were found between global
scores on the 16-item CIA and both, scores on the EDE-Q (rs¼ 0.89,
p< 0.001) and the clinicians’ impairment ratings (rs¼ 0.68,
p< 0.001) (see Table 2). These relationships were evident at each
time point (see Table 2) and remained (both p< 0.001) on ﬁtting
multilevel models.
Fig. 1 shows a box plot diagram of the global CIA scores for each
of the different severity ratings made by the clinicians. There was
a signiﬁcant deviation from linearity (F(4)¼ 11.9, p< 0.001),
reﬂecting the fact that three homogeneous groups were found on
post-hoc testing: those who received ratings of 0, 1 and 2 (little or
no impairment); those with ratings of 3 or 4 (moderate impair-
ment); and those with a rating of 5 or 6 (severe impairment).
Discriminant validity
The CIA global and domain scores of the 37 participants who (at
their ﬁrst CIA assessment) were judged to no longer have an eating
disorder were signiﬁcantly lower than those of the 33 participants
whowere judged to still be a ‘‘case’’ (global CIA score: 7.86 (6.83) vs
27.64 (12.44); t¼ 8.36, df¼ 68, p< 0.001) with similar scores being
observed across all 137 pairs of ratings. On ﬁttingmultilevel models
to allow for correlation between repeated assessment, signiﬁcant
effects of eating disorder status were observed for the global and
domain scores (all p< 0.001).
ROC analysis showed that the global CIA score was better able to
predict case status (area under curve¼ 0.88) than the three
Table 1
Component matrix showing rotated (varimax) loadings of each item on the three extracted components of the ﬁnal 16-item CIA questionnaire
Component
1 2 3
Personal impairment Social impairment Cognitive impairment
Eigenvalue 9.52 1.12 0.93
Item
Over the past month, to what extent have your eating habits,
exercising, or feelings about your eating, shape or weight.
made you feel ashamed of yourself 0.86
made you feel guilty 0.84
made you feel critical of yourself 0.80
made you feel a failure 0.77
made you upset 0.75
made you worry 0.71
interfered with meals with family or friends 0.80
made it difﬁcult to eat out with others 0.80
interfered with you doing things you used to enjoy 0.71
stopped you going out with others 0.63
interfered with your relationship with others 0.55
made you absent-minded 0.85
made you forgetful 0.82
affected your ability to make everyday decisions 0.68
affected your performance at work (if applicable) 0.63
made it difﬁcult to concentrate 0.45
Mean (SD) score 10.2 (6.05) 5.36 (4.58) 4.51 (4.01)
Median (range) 11 (0–18) 5 (0–15) 4 (0–15)
p-Value for unidimensionality 0.46 0.97 0.65
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0.85, and 0.80, respectively; with the cognitive domain performing
signiﬁcantly less well (p¼ 0.0014)). The best cut-point was a global
CIA score of 16, which had a sensitivity of 76% and speciﬁcity of 86%
(Fig. 2).
Sensitivity to change
Participants’ mean (SD) global CIA score dropped signiﬁcantly
from 31.2 (9.88) at the start of treatment to 8.22 (10.7) at the end
(t¼ 9.76, df¼ 22, p< 0.001). Similar changes were observed in each
domain score (all p< 0.001). In addition, there were signiﬁcant
positive correlations between change in global CIA score and
change in the clinicians’ impairment ratings (global score rs¼ 0.86,
p¼ 0.013).
Discussion
Eating disorders have a profoundly negative impact on patients’
lives, yet to date there is no satisfactory measure of this impair-
ment. Such a measure would be of great value in the clinical
assessment of patients and their response to treatment. It wouldTable 2
Mean (SD) global CIA score and clinicians’ impairment ratings at each assessment and o
Assessment N Global CIA
score (0–48)
Beginning of treatment 23 32.5 (11.1)
End of treatment 27 7.85 (5.43)
20-Week follow-up 22 11.0 (8.87)
40-Week follow-up 25 8.44 (7.08)
60-Week follow-up 18 10.2 (9.10)
2-Year follow-up 16 8.56 (7.50)
3-Year follow-up 6 14.0 (12.1)
Total 137 13.3 (12.1)
*Signiﬁcant at 0.05 level.
**Signiﬁcant at 0.01 level.
***Signiﬁcant at 0.001 level.also help inform epidemiological studies of the burden imposed by
eating disorder psychopathology.
The aim of this research was to develop a clinically useful
measure of the psychosocial impairment secondary to eating dis-
order features and to test its psychometric properties. To this end
the 16-item, self-report CIA was developed and its reliability, val-
idity, sensitivity to change and ability to predict eating disorder
case status were evaluated using data collected in the context of
a treatment trial.
It was found that the internal consistency of the preliminary 22-
item instrument was high and that all items correlated positively
with the global score. However, IRT analysis showed that the
questionnaire was signiﬁcantly non-unidimensional and that six
items either had a notable ﬂoor effect, signiﬁcantly misﬁt or were
inconsistent with the underlying construct. These items were
therefore excluded. The resulting 16-item instrument (the CIA) was
found to be unidimensional and showed high internal consistency.
Principal component analysis suggested the existence of three
factors (named ‘personal’, ‘social’, and ‘cognitive’), explaining 77%
of the variance. All three domains were also found to be unidi-
mensional, making it possible to use both global and domain-




4.39 (0.72) 0.692 (<0.001)***
2.11 (1.16) 0.322 (0.102)
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1.50 (1.38) 0.590 (0.010)*
1.69 (1.35) 0.633 (0.008)**
2.67 (1.75) 0.924 (0.008)**






























Fig. 1. Box plot of mean global CIA scores for the ﬁve levels of clinician-rated
impairment.
K. Bohn et al. / Behaviour Research and Therapy 46 (2008) 1105–1110 1109one construct. Given the content of the instrument and the fact that
its scores correlate closely with clinicians’ ratings of secondary
psychosocial impairment, it is highly likely that it is measuring
psychosocial impairment secondary to the presence of eating dis-
order features.
The test–retest reliability of the CIA was examined by admin-
istering the CIA twice within three days to participants with vary-
ing degrees of eating disorder psychopathology. It was found that
there was a statistically signiﬁcant positive correlation between the
CIA scores at the two time points. The scores were on average
slightly lower on the second occasion but the difference was small.
Overall, the ﬁndings suggest that the CIA has satisfactory test–
retest reliability.
Two tests of the construct validity of the CIA were conducted.
The ﬁrst was an indirect one and it involved comparing scores on
the EDE-Q and the CIA. A statistically signiﬁcant positive correlation
was found indicating that higher levels of eating disorder psycho-
pathology were associated with higher levels of secondary psy-
chosocial impairment. The second test involved comparing scores





















Area under ROC curve = 0.8789  
Fig. 2. ROC curve for the prediction of clinician-rated eating disorder status from the
global CIA score, with the arrow indicating the best cut-point (N¼ 137).made by expert clinicians. Again there was a strong positive cor-
relation between the two.
The discriminant validity of the CIAwas tested by comparing the
global and domain-speciﬁc CIA scores of patients with an eating
disorder with those of patients who were judged no longer to have
one. It was found that the scores of the two groups differed sig-
niﬁcantly. A ROC analysis revealed that a cut-point of 16 on the CIA
best predicted eating disorder case status, with a sensitivity of 76%
and a speciﬁcity of 86%.
Lastly, sensitivity to change was tested. It was found that there
was a signiﬁcant decrease in patients’ CIA global and domain scores
following cognitive behaviour therapy, and that there were signif-
icant positive correlations between change in clinician-rated sec-
ondary impairment and change in the global CIA score.
Certain points about this work are of note. First, this new in-
strument, the CIA, addresses impairment due to all the main ele-
ments of eating disorder psychopathology including concerns
about shape. None of the other measures explicitly assesses the
effect of such concerns despite the fact that they are central to the
‘‘core psychopathology’’ of the eating disorders (Fairburn, 2008). In
this study, patients are likely to have had all the main features of
their eating disorder at the forefront of their mind when com-
pleting the CIA, as they were asked to complete the EDE-Q,
a measure of all aspects of eating disorder psychopathology, im-
mediately before the CIA. A second strength of this research is that
many aspects of the performance of the CIA were tested including
sensitivity to change and ability to predict case status. Equivalent
data are not available for existing measures of eating disorder-
speciﬁc health-related quality of life. Third, the sample used is
likely to have been representative of many other outpatient sam-
ples of adults with an eating disorder, given its transdiagnostic
composition and the two catchment area-based sampling frames.
Fourth, the participants were assessed both before and after
treatment and over an extended period of follow-up. Therefore CIA
data were available on people with the full range of severity of
eating disorder psychopathology. This was important since we
wanted to test the CIA’s performance across its entire scoring range.
Lastly, the ability of the CIA to assess secondary psychosocial im-
pairment was validated against a simultaneous but independent
assessment of impairment made by expert clinicians, the best
available validator.
The main limitation of the study was the relatively small sample
size, especially given the need to employ subsets of the data for the
various analyses. Despite this, signiﬁcant associations were found,
all of which support the validity and utility of the CIA. Another
limitation is that the sample contained few patients with anorexia
nervosa.More data are needed on this subgroup of patients. Itmight
be thought that a limitation of the study of discriminant validitywas
the fact that no CIA data on healthy controls were used: instead,
discriminant validity was tested by comparing patients with a clin-
ical eating disorder with patients who were judged to no longer to
have one. In fact this was a particularly stringent test since the latter
participants were likely to have residual levels of eating disorder
psychopathology making discrimination more difﬁcult. Neverthe-
less it would be of value to have normative data on the CIA to
ascertain the degree of impairment that is associated with the level
of eating disorder features found in the general population. As al-
ways, it is important to stress that the ﬁndings require replication,
preferably using larger samples and ones differing in case compo-
sition, age and ethnicity. Finally, it should be recalled that the CIA
does not attempt to assess secondary physical impairment. This is
becausewedo not think it is possible for patients to reliably identify
those aspects of their physical functioning that are being impaired
exclusively as a result of their eating disorder. We recommend that
any assessment of secondary physical impairment should be made
by a physician alongside the administration of the CIA.
K. Bohn et al. / Behaviour Research and Therapy 46 (2008) 1105–11101110In conclusion, this paper has described the development and
performance of a brief self-report measure of the nature and se-
verity of the psychosocial impairment that arises from eating dis-
order psychopathology. The ﬁndings support the validity and utility
of the instrument.
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